Skip to main content

Table 3 Objective response rate to first-line treatment in patients with metastatic colorectal cancer

From: Right- and left-sided colorectal cancers respond differently to cetuximab

Response

RSCC

LSCRC

Chemotherapy alone group

Cetuximab group

Chemotherapy alone group

Cetuximab group

Total

61

33

56

77

Best ORR

16 (26.2)

12 (36.4)

16 (28.6)

38 (49.4)

CR

3 (4.9)

0 (0)

0 (0)

1 (1.3)

PR

13 (21.3)

12 (36.4)

16 (28.6)

37 (48.1)

SD

28 (45.9)

11 (33.3)

28 (50.0)

33 (42.8)

PD

14 (23.0)

10 (30.3)

12 (21.4)

4 (5.2)

NA

3 (4.9)

0 (0)

0 (0)

2 (2.6)

P value a

0.349

0.005

  1. All values are presented as the number of patients followed by the percentages in parentheses
  2. a The ORR to the first-line treatment was compared between the chemotherapy and cetuximab plus chemotherapy groups in RSCC and LSCRC patients, respectively
  3. ORR, objective response rate; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NA, not available. Other footnotes as in Table 1
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us